Clinical Outcomes With Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Systematic Review With Meta-Analysis
Author:
Affiliation:
1. Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, Toronto, Canada
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,General Medicine
Link
http://academic.oup.com/ecco-jcc/article-pdf/12/11/1302/26571633/jjy109.pdf
Reference33 articles.
1. A model-based economic evaluation of biologic and non-biologic options for the treatment of adults with moderately-to-severely active ulcerative colitis after the failure of conventional therapy;Tappenden;Pharmacoeconomics,2016
2. Systematic review: predicting and optimising response to anti-TNF therapy in Crohn’s disease - algorithm for practical management;Ding;Aliment Pharmacol Ther,2016
3. A systematic review on infliximab and adalimumab drug monitoring: levels, clinical outcomes and assays;Silva-Ferreira;Inflamm Bowel Dis,2016
4. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases;Mitrev;Aliment Pharmacol Ther,2017
5. American Gastroenterological Association Institute guideline on therapeutic drug monitoring in inflammatory bowel disease;Feuerstein;Gastroenterology,2017
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Use of immunomodulators in non-infectious uveitis: lights and shadows;Eye;2024-08-19
2. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08
3. Is infliximab therapy currently relevant in patients with inflammatory bowel diseases? (review);Koloproktologia;2024-06-21
4. Therapeutic drug monitoring in inflammatory bowel disease: A practical approach;Indian Journal of Gastroenterology;2024-02
5. Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn’s Disease: A Propensity Score–Matched Analysis;Inflammatory Bowel Diseases;2023-11-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3